Raleigh Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6
| Closed | -$1.97K | – | 627 |
|
|
2024
Q4 | $1.97K | Sell |
6
-6
| -50% | -$1.97K | ﹤0.01% | 837 |
|
|
2024
Q3 | $4.02K | Buy |
12
+5
| +71% | +$1.67K | ﹤0.01% | 730 |
|
|
2024
Q2 | $1.91K | Buy |
7
+4
| +133% | +$1.09K | ﹤0.01% | 788 |
|
|
2024
Q1 | $1.04K | Buy |
3
+2
| +200% | +$692 | ﹤0.01% | 842 |
|
|
2023
Q4 | $323 | Buy |
+1
| New | +$323 | ﹤0.01% | 1027 |
|
|
2023
Q2 | – | Sell |
-81
| Closed | -$38.8K | – | 846 |
|
|
2023
Q1 | $38.8K | Buy |
81
+47
| +138% | +$22.5K | 0.02% | 277 |
|
|
2022
Q4 | $14.3K | Buy |
34
+22
| +183% | +$9.25K | 0.01% | 372 |
|
|
2022
Q3 | $5K | Buy |
+12
| New | +$5K | ﹤0.01% | 473 |
|